Synthetic cannabinoid withdrawal
Synthetic cannabinoid withdrawal is a clinically significant cluster of symptoms, behaviors and/or physiological features, varying in degree of severity and duration, that occurs upon cessation or reduction of use of synthetic cannabinoids in individuals who have developed Synthetic cannabinoid dependence or have used synthetic cannabinoids for a prolonged period or in large amounts. Presenting features of Synthetic cannabinoid withdrawal may include irritability, anger, aggression, shakiness, insomnia and disturbing dreams, restlessness, anxiety, depressed mood and appetite disturbance. In the early phase, Synthetic cannabinoid withdrawal may be accompanied by residual features of intoxication from the drug, such as paranoid ideation and auditory and visual hallucinations.
ICD-11 diagnostic criteria
- zaprzestanie lub ograniczenie używania substancji
- wystąpienie objawów odstawiennych
How to recognise
In the ICD-11 framework, the core symptoms taken into account when recognising Synthetic cannabinoid withdrawal are:
- drażliwość
Differential diagnosis
When diagnosing Synthetic cannabinoid withdrawal, the following ICD-11 disorders should be considered in the differential diagnosis:
Frequently asked questions
How is Synthetic cannabinoid withdrawal diagnosed according to ICD-11?
According to ICD-11, the diagnostic criteria for Synthetic cannabinoid withdrawal (6C42.4) include: zaprzestanie lub ograniczenie używania substancji; wystąpienie objawów odstawiennych.
What disorders are in the differential diagnosis of Synthetic cannabinoid withdrawal?
The differential diagnosis of Synthetic cannabinoid withdrawal (6C42.4) includes: Zaburzenia związane z używaniem kannabinoidów pochodzenia roślinnego (6C41).
WHO ICD-11 source
View this entry in the official WHO ICD-11 browser: 6C42.4 – WHO ICD-11
Notes
Proszę zakodować również jednostkę chorobową (schorzenie) będące przyczyną
Open in interactive browser →